FDA NDC Directory · JSON-LD · Markdown

CISplatin

NDC 60505-6279 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerApotex Corp.
Marketing categoryAbbreviated NDA (generic) · App ANDA218868
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsCISPLATIN (1 mg/mL)
Marketing started20240913
Package count1

External sources

Source: openFDA. Public-domain (CC0).